Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multimodal therapy for interstitial cystitis.

Jeffrey R Dell1, C Lowell Parsons

  • 1Institute for Female Pelvic Medicine, Urogynecology and Reconstructive Pelvic Surgery, Obstetrics and Gynecology Consultants, P.C., Knoxville, Tennessee 37923, USA.

The Journal of Reproductive Medicine
|April 20, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) Diagnosis: Current Limitations and a Pragmatic Clinical Diagnostic Definition.

Neurourology and urodynamics·2025
Same author

Subclinical Infection of the Silicone Breast Implant Surface as a Possible Cause of Capsular Contracture.

Aesthetic plastic surgery·2020
Same author

Role of urinary cations in the etiology of interstitial cystitis: A multisite study.

International journal of urology : official journal of the Japanese Urological Association·2020
Same author

Chronic scrotal pain: A variable symptom of interstitial cystitis/bladder pain syndrome.

Urology annals·2019
Same author

Fractional CO<sub>2</sub> laser of the vagina for genitourinary syndrome of menopause: Is the out-of-pocket cost worth the outcome of treatment?

Lasers in surgery and medicine·2017
Same author

Editorial Comment.

The Journal of urology·2017

Pentosan polysulfate sodium (PPS) offers an effective oral treatment for interstitial cystitis (IC), targeting urothelial repair. A multimodal approach combining PPS with other therapies provides comprehensive management for IC symptoms and pain.

Area of Science:

  • Urology
  • Gynecology
  • Pharmacology

Background:

  • Interstitial cystitis (IC) presents diverse treatment challenges with historically limited effective therapies.
  • Dimethyl sulfoxide (DMSO) bladder instillation was the sole FDA-approved treatment, offering moderate efficacy but requiring an invasive procedure.

Purpose of the Study:

  • To review the therapeutic landscape for interstitial cystitis (IC).
  • To highlight the role of pentosan polysulfate sodium (PPS) in managing IC.
  • To discuss multimodal treatment strategies for IC.

Main Methods:

  • Review of existing literature on IC treatments.
  • Analysis of pentosan polysulfate sodium (PPS) efficacy and administration routes.
  • Evaluation of combination therapies and non-pharmacologic approaches for IC.

Related Experiment Videos

Main Results:

  • Pentosan polysulfate sodium (PPS) provides an effective and safe oral treatment option for IC, aiding urothelial repair.
  • Intravesical heparin sulfate or PPS can offer symptom relief, though not FDA-indicated.
  • Multimodal therapy, with PPS as a foundation, enhances pain and symptom management for moderate to severe IC.

Conclusions:

  • Pentosan polysulfate sodium (PPS) is a cornerstone for effective IC management.
  • Combining oral PPS with other pharmacologic agents and non-pharmacologic methods optimizes patient outcomes.
  • A multimodal strategy enables effective management of acute and chronic pain associated with IC.